Samsara BioCapital, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,915,842
+39.0%
345,2930.0%2.42%
+142.5%
Q2 2023$5,693,882
-7.6%
345,2930.0%1.00%
-21.5%
Q1 2023$6,160,027
-38.7%
345,2930.0%1.27%
-41.2%
Q4 2022$10,054,932
+18.9%
345,2930.0%2.16%
+9.7%
Q3 2022$8,460,000
+490.4%
345,2930.0%1.97%
+416.5%
Q2 2022$1,433,000
-64.0%
345,2930.0%0.38%
-61.8%
Q1 2022$3,978,000
+15.4%
345,2930.0%1.00%
+49.6%
Q4 2021$3,446,000
-12.1%
345,293
+15.0%
0.67%
+8.8%
Q3 2021$3,922,000
-33.3%
300,2930.0%0.62%
-15.3%
Q2 2021$5,880,000
+37.5%
300,293
+49.4%
0.73%
-8.0%
Q1 2021$4,276,000
-28.5%
201,0460.0%0.79%
+31.3%
Q4 2020$5,977,000
+17.4%
201,046
-14.4%
0.60%
-57.6%
Q3 2020$5,089,000
-17.4%
234,846
-15.0%
1.42%
-28.4%
Q2 2020$6,161,000
+46.5%
276,2890.0%1.98%
-18.1%
Q1 2020$4,205,000276,2892.42%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders